Literature DB >> 9727651

Microbiology of bacterial respiratory infections.

D Cappelletty1.   

Abstract

The upper respiratory tract may become susceptible to bacterial infection as a result of health conditions such as allergies and viral infections, as well as the effects of smoking and airborne environmental pollutants. Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis are the most common bacterial pathogens in upper and lower respiratory tract infections. Streptococcus pyogenes is the predominant bacterial pathogen in pharyngitis and tonsillitis. Bacterial pathogens adhere to mucous membranes and colonization ensues. In an otherwise healthy individual the host immune system responds to the invading bacteria resulting in edema and swelling. If antimicrobial treatment does not eradicate the invading organisms and successfully interrupt the progress of the infection, the patient may develop recurrent or chronic disease. S. pneumoniae and other pathogens once susceptible to penicillin and other antibiotics are now becoming resistant. Bacterial resistance has developed and disseminated because of the widespread use of antibiotics. Major mechanisms of bacterial resistance to antimicrobials in upper respiratory tract infections include enzymatic inhibition, membrane impermeability, alteration of target enzymes, active pumping out of antibiotic and alteration of the ribosomal target.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727651     DOI: 10.1097/00006454-199808001-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells.

Authors:  Brian Bullard; Serena L Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children.

Authors:  Qingfu Xu; Michael E Pichichero
Journal:  Vaccine       Date:  2013-12-16       Impact factor: 3.641

3.  Trends in antibiotic resistance of respiratory tract pathogens in children in Geneva, Switzerland.

Authors:  Thomas Jaecklin; Peter Rohner; Véronique Jacomo; Kurt Schmidheiny; Alain Gervaix
Journal:  Eur J Pediatr       Date:  2005-08-25       Impact factor: 3.183

Review 4.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Correlation of Bacterial Isolates from Middle Ear and Nasopharynx in Patients with Chronic Suppurative Otitis Media in Ilorin, Nigeria.

Authors:  Olushola Abdulrahman Afolabi; Foluwasayo Emmanuel Ologe; Charles Nwabuisi; Adekunle Ganiyu Salaudeen; Olalekan Tajudeen Ajiboye; Clement Chukwuemeka Nwawolo
Journal:  Malays J Med Sci       Date:  2015-09

6.  Haemophilus influenzae-protein D specific antibody correlate with protection against acute otitis media in young children.

Authors:  Anthony Almudevar; Michael E Pichichero
Journal:  Vaccine       Date:  2018-02-01       Impact factor: 3.641

Review 7.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

8.  The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities.

Authors:  Jennifer M Timpe; Melissa M Holm; Serena L Vanlerberg; Venkatesha Basrur; Eric R Lafontaine
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Modeling specific antibody responses to natural immunization to predict a correlate of protection against infection before commencing a clinical vaccine trial.

Authors:  Anthony Almudevar; Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.